DHA to award bridge contract to GDIT for Data Warehouse Services

0
301
kentoh ©123RF.com

Notice ID: JA-23-0017B
Previous Notice ID: HT9402-14-F-0006
Contract Award Date: Jan 31, 2023
Contract Award Number: HHSN316201200013W
Task/Delivery Order Number: HT9402-14-F-0006
Modification Number: P00071

This is an individual justification for a bridge action, resulting in an award of a Firm Fixed Price (FFP) modification to extend the period of performance for approximately16 months or July 24, 2024, for the General Dynamics Information Technology, Inc. (GDIT), Pharmacy Data Warehouse (PDW) task order for the management of TRICARE pharmacy transactions data repository. This bridge action will continue services supported under task order HHSN316201200013W / HT9402-14-F-0006.

This bridge action is needed because the re-compete requirement was placed on hold due to lapse in funding and to allow for a GOGO version of the PDW to be built. The bridge action is needed to avoid a lapse in service. The current task order may not be extended after July 24, 2024 as the NIH contract does not allow performance under task orders to exceed 10 years. Failure to extend the PDW task order will create a disruption in services and patient safety issues affecting all TRICARE beneficiaries using the DHA Pharmacy Benefit by not being able to provide crucial commercial drug data to Government agencies in regard to a beneficiary’s drug contradiction information, disproportionate drug use, and/or excessive prescriptions written by providers. Additionally, Military Health System (MHS) staff, the commercial pharmacy industry, DHA Program Integrity (PI), and Government agencies external to DHA will be negatively impacted because they rely on the data provided from the pharmacy data warehouse for analysis relating to Congressional reports involving pharmacoeconomics, utilization, trending, fraud waste and abuse, and, outcomes research…

Read more here.

Related Item

DHA to award bridge contract to GDIT for Data Warehouse Services (November 6, 2020)

LEAVE A REPLY

Please enter your comment!
Please enter your name here